HealthIT Answers November 19, 2021
Will Consider Other Coverage Pathways to Enhance Access to Innovative Medical Devices
The Agency will explore evidence-based approaches that protect people with Medicare
The Centers for Medicare and Medicare Services (CMS) (@CMSGov) is rescinding the Medicare Coverage of Innovative Technology and Definition of “Reasonable and Necessary” (MCIT/R&N) final rule because of concerns that the provisions in the final rule may not have been sufficient to protect Medicare patients. By rescinding this rule, CMS can take action that will better address those safety concerns in the future.
“Although we continue to be in favor of enhancing access to new technologies, we are mindful that they may have unknown or unexpected risks and must first ensure such technologies improve health outcomes for...